Compare FMC Corp (FMC) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Marsh & McLennan Companies, Inc. — how do they compare? FMC Corp trades at $11.44 (market cap $1.36B), while Marsh & McLennan Companies, Inc. trades at $181.1 (market cap $84.90B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 62.4× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | MRSH | |
|---|---|---|
Market Cap | $1.36B | $84.90B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $212.28 |
52-Week Low | $10.72 | $157.32 |
Enterprise Value | $5.50B | $105.74B |
Dividend Yield | 2.95% | 2.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Marsh (MRSH) trades at $181.18, up 1.76% today, near its R3 resistance of $181. The stock shows a bullish technical signal, with recent earnings beats and a 10% dividend increase to $0.99 per share. Revenue grew to $26.98B in 2025, with a net income margin of 14.26%, while the P/E ratio stands at 22.03. Analyst consensus is a buy rating from 11 of 33 analysts, with a price target of $203.67.
The outlook is positive with sustained organic growth and shareholder returns, but risks include rising operating expenses and a premium valuation. Earnings growth and AI initiatives are key catalysts, though softer insurance pricing and debt levels warrant monitoring for potential volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →
